Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qudu Zengning Capsule Phase II in HIV/AIDS
CTR20170760Phase 2Suspended
- Sponsor
- Century Kang Pharmaceutical
- Start
- Jul 2017
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Qudu Zengning in human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), sponsored by Century Kang Pharmaceutical. Started Jul 2017; status: suspended.
02
Drugs
Qudu Zengning
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on CTR20170760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170760.